NasdaqGS:NVAXBiotechs
Novavax (NasdaqGS:NVAX) And Takeda Amend Collaboration For SARS-CoV-2 Vaccine In Japan
Novavax (NasdaqGS:NVAX) recently amended its collaboration agreement with Takeda, enhancing its revenue potential through a new upfront payment structure and future royalties. These developments, along with the appointment of Charles Newton to the board, signal a strategic shift towards strengthening the company's market position. This comes at a time when the broader market has experienced moderate volatility, with minor shifts amid ongoing tariff discussions and a Federal Reserve meeting,...